EAU26 highlights: Day 4
Check out these highlights from the last day of EAU26 in London. You can access two webcasts of presentations, read session reports, and watch an expert roundtable discussion on EAU TV about the global men's health crisis.
Must-view webcasts
- Game Changer Session: Enhanced Diagnostic Accuracy and Earlier Relapse Detection with Sequential MicroRNA-371 Testing in Stage I Testicular Germ Cell Tumors: A Prospective Multi-Institutional Cohort Study. By: Dr. E. Kaufmann, Lucerne (CH). Watch webcast presentation here.
- Special Session: Take home messages for NMIBC and UTUC. By: Prof. J. Boormans, Rotterdam (NL). Watch webcast presentation here.
Session report: A focus on the Stockholm3 test and gut microbiome
Integrating the Stockholm3 test as a reflex biomarker with an OPT programme substantially reduces the number of MRI scans and biopsy procedures in the first testing round. What other significant findings did the the best oncology abstract show? Are there caveats? Find out more in this article on the Special Session “EAU26 Abstract prizes: An expert discussion”.
Session report: Renal and rare cancers - “Preserving the cure while minimising harm”
At the Plenary Session on renal and rare cancers on the final day of EAU26 in London, much attention was given to the latest diagnostic and treatment options, be it through case discussions or state-of-the-art presentations on the latest discoveries around kidney tumour subtypes.
EAU TV
In this discussion, experts explore the growing challenges in men’s health. From sexual dysfunction in young men to lifestyle, fertility and digital health solutions, the session highlights key trends, causes and potential strategies for improving men’s health in modern healthcare.
EAU26 Resource Centre
View webcasts, videos, posters and full-text abstracts are currently accessible via the EAU26 Resource Centre wherein delegates have full access. If you did not attend the congress, you can still register for on-demand access to explore all of EAU26 scientific content.

